2.4200
-0.0800
(-3.20%)
At close: 4:00:01 PM EST
2.4200
0.00
(0.00%)
After hours: 4:01:42 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ARCH VENTURE FUND IX, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 2, 2024 | -- |
BUROW KRISTINA M Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 2, 2024 | -- |
CRANDELL KEITH L. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 2, 2024 | -- |
LIM JONATHAN E Director | Conversion of Exercise of derivative security | Apr 2, 2024 | -- |
RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 2, 2024 | -- |
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN I L Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Apr 2, 2024 | 556,233 |
Related Tickers
ARTV Artiva Biotherapeutics, Inc.
9.35
-8.87%
CTNM Contineum Therapeutics, Inc.
13.29
-0.60%
RAPP Rapport Therapeutics, Inc.
14.81
-11.26%
SEPN Septerna, Inc.
17.99
-13.72%
ANRO Alto Neuroscience, Inc.
4.3500
-1.36%
ZBIO Zenas BioPharma, Inc.
8.12
-12.50%
ANTX AN2 Therapeutics, Inc.
1.2500
-3.85%
CAMP CAMP4 THERAPEUTICS CORPORATION
4.0600
-8.76%
CLYM Climb Bio, Inc.
2.0000
+6.95%
ARTL Artelo Biosciences, Inc.
1.1600
+4.50%